Related Experiment Videos
Aqueous urea solution destabilizes Abeta(16-22) oligomers.
D K Klimov1, John E Straub, D Thirumalai
1Bioinformatics and Computational Biology Program, School of Computational Sciences, George Mason University, Manassas, VA 20110, USA. dklimov@gmu.edu
Summary
Urea disrupts amyloidogenic peptide oligomers by interacting with the peptide backbone, promoting beta-strand formation in monomers while destabilizing the overall structure. This mechanism suggests urea destabilizes other amyloidogenic peptides too.
Area of Science:
- Biochemistry
- Molecular Biophysics
- Computational Chemistry
Background:
- Amyloidogenic peptides, such as Abeta(16-22), are prone to forming oligomeric structures implicated in diseases.
- The role of denaturants like urea in modulating peptide aggregation and stability is crucial for understanding disease mechanisms and developing therapeutic strategies.
Purpose of the Study:
- To investigate the effect of aqueous urea solutions on the stability of Abeta(16-22) peptide oligomers.
- To elucidate the molecular mechanisms underlying urea-induced destabilization of these peptide structures.
Main Methods:
- Utilized long multiple trajectories from molecular dynamics simulations.
- Employed two different urea models to ensure robustness of findings.
- Analyzed peptide backbone interactions and secondary structure formation.
Main Results:
- High urea concentrations promote beta-strand formation in Abeta(16-22) monomers, contrasting with compact random coil structures in water.
- Urea destabilizes stable antiparallel beta-sheet structures of tripeptide systems.
- Direct urea-peptide backbone interactions enhance beta-strand content and disrupt oligomeric structures.
Conclusions:
- Oligomer unbinding dynamics are influenced by opposing effects: increased monomer beta-strand propensity and rapid oligomer disruption.
- The destabilization mechanism relies on hydrogen bond formation between urea and the peptide backbone.
- High urea concentrations are predicted to destabilize oligomers of other amyloidogenic peptides.